Application Sponsors
ANDA 087672 | MYLAN PHARMS INC | |
Marketing Status
Application Products
001 | TABLET;ORAL | 5MG | 0 | METHYCLOTHIAZIDE | METHYCLOTHIAZIDE |
FDA Submissions
| ORIG | 1 | AP | 1982-08-17 | |
LABELING; Labeling | SUPPL | 3 | AP | 1989-12-26 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1990-01-31 | |
LABELING; Labeling | SUPPL | 5 | AP | 1991-07-01 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 1993-10-15 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 1998-02-05 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 1998-02-25 | |
Submissions Property Types
SUPPL | 4 | Null | 0 |
SUPPL | 7 | Null | 0 |
SUPPL | 8 | Null | 0 |
SUPPL | 9 | Null | 0 |
CDER Filings
MYLAN PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 87672
[companyName] => MYLAN PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"METHYCLOTHIAZIDE","activeIngredients":"METHYCLOTHIAZIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"METHYCLOTHIAZIDE","submission":"METHYCLOTHIAZIDE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)